evidence-informed practice/policy

Canadian Spontaneous Coronary Artery Dissection Study

Spontaneous coronary artery dissection (SCAD) occurs when there is a tear in the inner layers of a blood vessel in the heart, causing blockage and reducing blood flow and oxygen to the heart. It is an emergency condition that can result in heart attack and even death. Unfortunately, the causes of SCAD are poorly understood, and it is often misdiagnosed and mistreated.

Primary Investigator: 
Year: 
2019

Clinical, biological, and prognostic impact of supplemental oxygen in fibrotic interstitial lung disease

Interstitial lung disease (ILD) is a progressive lung disorder with no effective treatment. Oxygen is often used to relieve symptoms at the end of life, but the evidence supporting oxygen use in these patients is based on limited data from other diseases. The lack of data on the benefits of oxygen in patients with ILD has resulted in uncertain criteria for its use and limited access to this potentially important medication.

Primary Investigator: 
Year: 
2019

Towards TB elimination in Canada: Optimizing tuberculosis screening and prevention

The World Health Organization (WHO) aims to eliminate TB by 2050, but Canada is not on target to meet that goal. To reach our national TB elimination targets, we must reduce TB rates by 10% per year but we are only reducing TB rates by 2% per year. My research program is aimed at developing evidence to improve TB screening, prevention and treatment policies in order to accelerate TB elimination in British Columbia (BC) and Canada.  

Primary Investigator: 
Year: 
2019

Improving the methods of economic evaluation to support decision-making: CAR-T, uncertainty, and real-world evidence

The emergence of novel technologies in health care is associated with promising opportunities to improve patient health outcomes. Advances in health technologies also come at a substantial cost. New gene therapies have been estimated to cost between $300,000-$4,000,000 per patient. These new therapies offer promise, but do not offer certainty; decision-makers have to choose whether to reimburse the therapy with little evidence for how it might work in the real-world.

Primary Investigator: 
Award Type: 
Year: 
2019

Precision medicine to drive prevention and management strategies for women with endometrial cancer

Endometrial cancer (EC), or cancer of the uterus, is the most common gynecological cancer in Canada, with new cases and deaths increasing annually, due to an increase in the rate of common risk factors, like obesity. In British Columbia, the number of new EC cases is projected to increase by 50% and mortality to double by 2031. We must investigate economically feasible prevention strategies to control the rate of this cancer.

Primary Investigator: 
Award Type: 
Year: 
2019

Building intersections for vibrant rural communities (Building Intersections 2018)

Co-leads:

  • Katrina Plamondon 
    Interior Health
  • Jude Kornelsen 
    Centre for Rural Health Research / University of British Columbia
  • Amanda McDougall
    Interior Health
  • Kim Barnes 
    Interior Health

Trainee:

Primary Investigator: 
Award Type: 
Year: 
2017

Learning from the lived experiences of aging immigrants

Co-leads:

  • Sharon Koehn
    Centre for Healthy Aging / Simon Fraser University
  • Kahir Lalji
    United Way of the Lower Mainland

Team members:

Primary Investigator: 
Award Type: 
Year: 
2017

Autism community connects: A co-design web-platform to facilitate the uptake of research evidence by families

Co-leads:

  • Suzanne Lewis
    Pacific Autism Family Network / University of British Columbia
  • Dawn McKenna
    Pacific Autism Family Network

Team member:

  • Caylee Raber
    Emily Carr University

Trainee:

Primary Investigator: 
Award Type: 
Year: 
2017

Improving Mental Health Act rights advice communications and practices

Co-leads:

  • Kimberly Miller
    Simon Fraser University
  • Vanessa Bland 
    Vancouver Coastal Health

Team members:

Primary Investigator: 
Award Type: 
Year: 
2017

The impact of opioid agonist treatment on antipsychotic adherence among justice-involved patients in British Columbia

Substance dependence and mental illness frequently co-occur, presenting challenges to treatment providers and increasing the likelihood of suicide, drug overdose, and criminal justice involvement. Assessment and treatment of concurrent disorders (CD) have been identified by police, health professionals, and the Auditor General as urgent priorities in BC, and leadership in the treatment of CD is integral to the mandate of the Provincial Health Services Authority. 

Primary Investigator: 
Award Type: 
Year: 
2018

Improving youth mental health and substance use outcomes through primary-care based health services

Mental health and substance use (MHSU) disorders affect 1 in 4 Canadian youth. Of all age groups, young Canadians (ages 15 to 24) have the poorest access to health services. In response, British Columbia (BC) established a primary health initiative called 'Foundry' to promote and support early treatment for young people with MHSU disorders. Foundry is comprised of seven centres that provide integrated, coordinated health services for young people.

Primary Investigator: 
Award Type: 
Year: 
2018

Improving outcomes in the treatment of eating disorders: Self-compassion in patients, families and clinicians

Self-compassion refers to an individual's capacity to be mindful, recognize our common humanity in times of hardship, and to practice self-kindness in times of suffering. It has been shown to be beneficial in working with individuals with chronic health conditions, such as HIV/AIDS, diabetes, and eating disorders. However, many individuals have difficulty with this skill and experience barriers to being self-compassionate. 

Primary Investigator: 
Year: 
2018
Subscribe to RSS - evidence-informed practice/policy